Wells Fargo’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-161,296
Closed -$2.7M 7875
2022
Q4
$2.7M Buy
161,296
+42,982
+36% +$726K ﹤0.01% 2548
2022
Q3
$2.03M Buy
118,314
+102,671
+656% +$1.61M ﹤0.01% 2730
2022
Q2
$123K Sell
15,643
-25,074
-62% -$215K ﹤0.01% 4532
2022
Q1
$450K Sell
40,717
-40,944
-50% -$459K ﹤0.01% 4487
2021
Q4
$1.44M Buy
81,661
+65,602
+409% +$1.27M ﹤0.01% 3815
2021
Q3
$325K Sell
16,059
-11,540
-42% -$297K ﹤0.01% 4899
2021
Q2
$912K Sell
27,599
-24,562
-47% -$927K ﹤0.01% 4267
2021
Q1
$2.04M Sell
52,161
-71,022
-58% -$3.33M ﹤0.01% 3682
2020
Q4
$5.38M Buy
123,183
+25,220
+26% +$862K ﹤0.01% 2677
2020
Q3
$2.78M Buy
97,963
+68,082
+228% +$2.15M ﹤0.01% 3053
2020
Q2
$1.09M Sell
29,881
-9,171
-23% -$258K ﹤0.01% 3748
2020
Q1
$709K Buy
+39,052
New +$856K ﹤0.01% 3780

Wells Fargo's ONEM Position: Q1 2023 in Review

Wells Fargo sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 161,296 shares — an estimated $2.7M sold.

Wells Fargo first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $5.38M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Wells Fargo reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Wells Fargo sold 161,296 1Life Healthcare shares in Q1 2023, an estimated $2.7M.
  • Wells Fargo first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Wells Fargo's 1Life Healthcare position peaked at $5.38M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.